## Distinguishing True from False Features of Giant Cell Tumor ### Correct Features (Options 0, 1, 2) **Key Point:** Giant cell tumor of bone is a benign but locally aggressive tumor with characteristic clinicopathologic features. **Option 0 — Location after physeal closure:** GCT arises in the **epiphyseal-metaphyseal region** after skeletal maturity (physeal closure). This is a hallmark distinguishing feature — GCT does NOT occur in skeletally immature patients. [cite:Robbins 10e Ch 26] **Option 1 — Histologic composition:** The diagnostic histology shows: - Numerous **multinucleated giant cells** (resembling osteoclasts) - **Mononuclear stromal cells** (neoplastic component) - Hemosiderin deposits and fibrosis **Option 2 — Cell of origin:** GCT arises from **neoplastic transformation of osteoclast precursor cells** (monocyte/macrophage lineage), not from osteoblasts or fibroblasts. This explains the prominent giant cell population. ### FALSE Feature (Option 3 — The Correct Answer) **Warning:** Malignant transformation of GCT to osteosarcoma is **RARE**, occurring in <2–5% of cases, NOT >40%. This is a critical distinction: | Feature | GCT | Osteosarcoma | |---------|-----|---------------| | Malignant transformation rate | <5% | N/A (primary malignancy) | | Typical age of onset | 20–40 years | 10–20 years | | Location | Epiphyseal-metaphyseal | Metaphyseal | | Prognosis with surgery | Excellent | Poor without chemotherapy | **High-Yield:** GCT is fundamentally **benign** with excellent prognosis after surgical excision. Recurrence (not malignant transformation) is the main concern, occurring in 10–20% of cases depending on surgical technique and adjuvant therapy. **Clinical Pearl:** The risk of malignant transformation increases only after **radiation therapy** (historically used as adjuvant). Modern practice avoids radiation; curettage with adjuvants (phenol, liquid nitrogen, or cement) is preferred. ## Summary Table: GCT vs. Mimics | Feature | GCT | Osteoblastoma | Aneurysmal Bone Cyst | |---------|-----|----------------|---------------------| | Age | 20–40 | 10–30 | 10–30 | | Location | Epiphyseal-metaphyseal | Diaphyseal/metaphyseal | Metaphyseal | | Lytic pattern | Soap-bubble | Well-defined | Multilocular | | Giant cells | Numerous, neoplastic | Few, reactive | Absent | | Malignant risk | <5% | None | None |
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.